BioSpace News Archive

Press Releases

Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024

October 30, 2024
·
1 min read
Press Releases

Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis

October 30, 2024
·
4 min read
Press Releases

PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024

October 30, 2024
·
1 min read
Press Releases

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

October 30, 2024
·
1 min read
Press Releases

ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference

October 30, 2024
·
8 min read
Press Releases

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

October 30, 2024
·
1 min read
Press Releases

Noema Pharma Announces First Patients Dosed in Phase 2b Study with Gemlapodect (NOE-105), a First-In-Class Investigational Therapy for Tourette Syndrome

October 30, 2024
·
2 min read
Press Releases

LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024

October 30, 2024
·
1 min read
Press Releases

Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024

October 30, 2024
·
10 min read
Press Releases

Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3

October 30, 2024
·
8 min read